Does benralizumab effectively treat chronic obstructive pulmonary disease? A protocol of systematic review and meta-Analysis

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Background:This study aims to investigate the efficacy and safety of benralizumab for the treatment of patients with chronic obstructive pulmonary disease (COPD).Methods:This study will systematically and comprehensively search relevant literatures in electronic databases (MEDLINE, EMBASE, Cochrane Library, Global health, PsycINFO, Scopus, WANGFANG, and CNKI) from inception to the present without language and publication time restrictions. Two reviewers will independently carry out literature identification, data collection, and study quality assessment. Any disagreement will be settled down by a third reviewer through discussion and a consensus will be reached. RevMan 5.3 software will be used for statistical analysis performance.Results:This study will summarize up-To-date evidence to assess the efficacy and safety of benralizumab for the treatment of COPD.Conclusion:The findings of this study will provide helpful evidence to determine whether benralizumab is effective or not for the treatment of COPD.Systematic review registration:INPLASY202040039.

Cite

CITATION STYLE

APA

Chen, R., Wang, K. X., Meng, X., & Zhou, W. (2020). Does benralizumab effectively treat chronic obstructive pulmonary disease? A protocol of systematic review and meta-Analysis. Medicine (United States). Lippincott Williams and Wilkins. https://doi.org/10.1097/MD.0000000000020241

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free